Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: drugs  cost  medication  medical  health  money  prices  saving  multivu  8478051  rejuvenaging  getting  older  ronald  kaiser  doctor  living  with  old  age  simple  living  book  trailer  cancer  kids  childhood  micah  awareness  st  baldrick  foundation  research  health  medical  multivu  8284352  health  medical  device  3d  fda  gore  procedure  stroke  heart  multivu  8301551  health  hospital  medicine  healthcare  treatments  new  technology  northwestern  medicine  multivu  8213351  disease  health  research  healthcare  treatment  technology  new  help  wellness  multivu  8268751  pancreatic  cancer  health  disease  symposium  awareness  treatments  survivors  multivu  8213752  researchers  dietary  banned  stimulants  unapproved  pills  recall  medical  multivu  8216951  healthcare  health  data  technology  physicians  clinical  medicomp  it  multivu  8189651  woman  health  comfort  replens  gel  dryness  vaginal  menopause  multivu  8066251  delta  technology  health  medtech  medical  fda  lithotripter  new  healthcare  multivu  8134451  webmd  health  healthcare  medical  treatment  migraine  headache  robin  roberts  multivu  7579759 
Search // clinical
Results 1-12 of 101 for ' clinical ' (0 seconds)
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S. Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose. To view the multimedia release go to: https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Categories // Miscellaneous 
Added: 1867 days ago by MultiVuVideos
Runtime: 1m5s | Views: 620 | Comments: 0
Not yet rated
 

 

 

It’s inevitable that we’re all going to age, but Dr. Ronald Kaiser has discovered a way to make it enjoyable. In his new book Rejuvenaging: The Art and Science of Growing Older with Enthusiasm, Dr. Kaiser lays out the path to not only embracing our later years but making them the best half of our lives. Drawing on more than a half-century of clinical experience, and 80 years of living, Kaiser shares his simple plan to success. Find out more at http://www.thementalhealthgym.com/ Non-Fiction/Self Help
Categories // Miscellaneous 
Added: 1879 days ago by cosproductions
Runtime: 1m3s | Views: 802 | Comments: 0
Not yet rated
 

 

 

When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available. In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available. To view the multimedia release go to: https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Categories // Miscellaneous 
Added: 2022 days ago by MultiVuVideos
Runtime: 2m26s | Views: 698 | Comments: 1
Not yet rated
 

 

 

Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.* To view the multimedia release go to: https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Categories // Miscellaneous 
Added: 2176 days ago by MultiVuVideos
Runtime: 1m8s | Views: 657 | Comments: 5
Not yet rated
 

 

 

After nearly eight years of careful planning, guests from across Illinois gathered today in Lake Forest to celebrate the ceremonial opening of the new Northwestern Medicine Lake Forest Hospital, which will officially open on March 3, 2018. The new state-of-the-art hospital, which broke ground in 2014, will provide patients convenient access to world-class physicians with seamless access to Northwestern Memorial Hospital, Illinois’s premier academic medical center when needed. The new Lake Forest Hospital will offer cutting-edge treatments and innovative clinical trials within a world class health system. To view the multimedia release go to: https://www.multivu.com/players/English/8213351-new-northwestern-medicine-lake-forest-hospital/
Categories // Miscellaneous 
Added: 2225 days ago by MultiVuVideos
Runtime: 1m6s | Views: 615 | Comments: 2
Not yet rated
 

 

 

TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials. One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients. To view the multimedia release go to: https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Categories // Miscellaneous 
Added: 2231 days ago by MultiVuVideos
Runtime: 1m28s | Views: 600 | Comments: 4
Not yet rated
 

 

 

Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols. When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.” To view the multimedia release go to: https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Categories // Miscellaneous 
Added: 2246 days ago by MultiVuVideos
Runtime: 3m51s | Views: 624 | Comments: 3
Not yet rated
 

 

 

Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology. The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks. To view the multimedia release go to: https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
Categories // Miscellaneous 
Added: 2321 days ago by MultiVuVideos
Runtime: 1m33s | Views: 706 | Comments: 2
Not yet rated
 

 

 

According to recent survey by Medicomp Systems, 43 percent of healthcare IT professionals and physicians cited that their top data-related challenge was not a lack of data but rather the struggle to access the right data at the right time. Those findings aren't surprising since the vast majority of health information systems today share a common design flaw: they don't think and work the way physicians do at the point of care. However, they are still deeply concerning. To deliver the best patient care, physicians need clinically relevant data that is seamlessly presented within their current workflows and integrated into the same workspace. The result is not only better patient care and better outcomes but also higher clinical effectiveness, efficiency, and satisfaction. To view the multimedia release go to: https://www.multivu.com/players/English/8189651-medicomp-systems-ebook-healthcare-data-challenges/
Categories // Miscellaneous 
Added: 2322 days ago by MultiVuVideos
Runtime: 1m44s | Views: 498 | Comments: 2
Not yet rated
 

 

 

The complete solution to managing vaginal dryness and discomfort inside and out is now available to the millions of women changing physically, emotionally and hormonally every day. The maker of #1 doctor recommended Replens™ vaginal moisturizer introduces hormone-free and fragrance-free Replens™ Moisture Restore External Comfort Gel, for soothing relief from external vaginal dryness, in menopause, post-partum, and after a cancer diagnosis. “Ladies, don’t despair. Vaginal dryness can be a nuisance at any age. It’s one of the most common symptoms of menopause and unfortunately, can worsen over time. Luckily, there are non-hormonal products like Replens,” says Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University. “I recommend these products to patients as first line therapies to help relieve internal and external vaginal dryness.” To view the multimedia release go to: https://www.multivu.com/players/English/8066251-replens-vaginal-moisture-restore-external-comfort-gel/
Categories // Miscellaneous 
Added: 2407 days ago by MultiVuVideos
Runtime: 0m52s | Views: 498 | Comments: 1
Not yet rated
 

 

 

Today, WebMD released In Their Own Words: Moving Beyond Migraine with Robin Roberts, a new five-part video series that sheds light on the debilitating nature of migraine and the impact it has on all aspects of a sufferer’s personal and professional life. To learn more about treatments and the individuals featured in In Their Own Words: Moving Beyond Migraine with Robin Roberts, visit: to www.webmd.com/insidemigraines. Moving Beyond Migraine follows the lives of Jennifer, a public school administrator who has lived with intense migraine headaches for over 20 years; Kate, a 20-year-old college student with debilitating migraines that have run in her family for generations; Melanie, whose intense migraine condition has altered the dynamics of her nine year marriage; and Lynn, who after suffering from migraine for 50 years, shares how a clinical trial for a new treatment called CGRP targeted therapy is finally providing her with some relief. To view the multimedia release go to: https://www.multivu.com/players/English/7579759-robin-roberts-moving-beyond-migraine/
Categories // Miscellaneous 
Added: 2457 days ago by MultiVuVideos
Runtime: 1m4s | Views: 677 | Comments: 1
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 2461 days ago by MultiVuVideos
Runtime: 4m28s | Views: 560 | Comments: 1
Not yet rated
 

 

 

Page 1 of 9  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.